Virginiamycin
(MVTQIFVKRXBCHS-UHFFFAOYSA-N)
Structure
- SMILES
- O=C1NCC=CC(=CC(O)CC(=O)Cc2nc(C(=O)N3C(=CCC3)C(=O)OC(C(C=C1)C)C(C)C)co2)C.CCC1NC(=O)C(NC(=O)c2ncccc2O)C(C)OC(=O)C(NC(=O)C2N(C(=O)C(N(C(=O)C3N(C1=O)CCC3)C)Cc1ccccc1)CCC(=O)C2)c1ccccc1
- Molecular Formula:
- C71H84N10O17
- Molecular Weight:
- 1349.480
- Log P:
- 4.9923
- Hydrogen Bond Acceptor:
- 27
- Hydrogen Bond Donor:
- 6
- TPSA:
- 363.76
- CAS Number(s):
- 11006-76-1; 270076-60-3
Synonym(s)
1.
Virginiamycin
2.
Staphylomycin
3.
Antibiotic 899
4.
Eskalin
5.
Founderguard
6.
Stajac
7.
Virgimycine
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Ageusia | OFFSIDES | ||
| 2 | Angioedema | OFFSIDES | ||
| 3 | Bronchitis | OFFSIDES | ||
| 4 | Cell Death | OFFSIDES | ||
| 5 | Cheilitis | OFFSIDES | ||
| 6 | Conjunctival deposit | OFFSIDES | ||
| 7 | Craniotomy | OFFSIDES | ||
| 8 | Drug resistance | OFFSIDES | ||
| 9 | Erysipelas | OFFSIDES | ||
| 10 | Erythrodermic psoriasis | OFFSIDES | ||
| 11 | Hyperventilation | OFFSIDES | ||
| 12 | Immunosuppressant drug level | OFFSIDES | ||
| 13 | Lactobacillus infection | OFFSIDES | ||
| 14 | Protein total increased | OFFSIDES | ||
| 15 | Pustular psoriasis | OFFSIDES | ||
| 16 | Rhonchi | OFFSIDES | ||
| 17 | Thrombophlebitis | OFFSIDES | ||
| 18 | Vaginal contraceptive device expelled | OFFSIDES | ||
| 19 | treatment failure | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.